Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Evaluating the effects of SARS-CoV-2 Spike mutation D614G on transmissibility and pathogenicity

View ORCID ProfileErik M. Volz, View ORCID ProfileVerity Hill, JT McCrone, View ORCID ProfileAnna Price, View ORCID ProfileDavid Jorgensen, View ORCID ProfileÁine O’Toole, Joel Southgate, Robert Johnson, Ben Jackson, Fabricia F. Nascimento, Sara M. Rey, View ORCID ProfileSamuel M. Nicholls, Rachel M. Colquhoun, Ana Da Silva Filipe, Nicole Pacchiarini, Matthew Bull, Lily Geidelberg, Igor Siveroni, Ian G. Goodfellow, Nicholas J. Loman, Oliver Pybus, David L. Robertson, View ORCID ProfileEmma C. Thomson, Andrew Rambaut, View ORCID ProfileThomas R. Connor on behalf of the CoG-UK consortium
doi: https://doi.org/10.1101/2020.07.31.20166082
Erik M. Volz
1Department of Infectious Disease Epidemiology and MRC Centre for Global Infectious Disease Analysis, Imperial College London
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Erik M. Volz
  • For correspondence: e.volz@imperial.ac.uk a.rambaut@ed.ac.uk ConnorTR@cardiff.ac.uk
Verity Hill
2Institute of Evolutionary Biology, University of Edinburgh
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Verity Hill
JT McCrone
2Institute of Evolutionary Biology, University of Edinburgh
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Anna Price
3School of Biosciences, Cardiff University
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Anna Price
David Jorgensen
1Department of Infectious Disease Epidemiology and MRC Centre for Global Infectious Disease Analysis, Imperial College London
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for David Jorgensen
Áine O’Toole
2Institute of Evolutionary Biology, University of Edinburgh
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Áine O’Toole
Joel Southgate
3School of Biosciences, Cardiff University
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Robert Johnson
1Department of Infectious Disease Epidemiology and MRC Centre for Global Infectious Disease Analysis, Imperial College London
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ben Jackson
2Institute of Evolutionary Biology, University of Edinburgh
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Fabricia F. Nascimento
1Department of Infectious Disease Epidemiology and MRC Centre for Global Infectious Disease Analysis, Imperial College London
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Sara M. Rey
4Pathogen Genomics Unit, Public Health Wales NHS Trust
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Samuel M. Nicholls
5Institute of Microbiology and Infection, University of Birmingham
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Samuel M. Nicholls
Rachel M. Colquhoun
2Institute of Evolutionary Biology, University of Edinburgh
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ana Da Silva Filipe
8MRC-University of Glasgow Centre for Virus Research
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Nicole Pacchiarini
4Pathogen Genomics Unit, Public Health Wales NHS Trust
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Matthew Bull
4Pathogen Genomics Unit, Public Health Wales NHS Trust
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Lily Geidelberg
1Department of Infectious Disease Epidemiology and MRC Centre for Global Infectious Disease Analysis, Imperial College London
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Igor Siveroni
1Department of Infectious Disease Epidemiology and MRC Centre for Global Infectious Disease Analysis, Imperial College London
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ian G. Goodfellow
6Department of Pathology, University of Cambridge
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Nicholas J. Loman
5Institute of Microbiology and Infection, University of Birmingham
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Oliver Pybus
7Department of Zoology, University of Oxford
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
David L. Robertson
8MRC-University of Glasgow Centre for Virus Research
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Emma C. Thomson
8MRC-University of Glasgow Centre for Virus Research
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Emma C. Thomson
Andrew Rambaut
2Institute of Evolutionary Biology, University of Edinburgh
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: e.volz@imperial.ac.uk a.rambaut@ed.ac.uk ConnorTR@cardiff.ac.uk
Thomas R. Connor
3School of Biosciences, Cardiff University
4Pathogen Genomics Unit, Public Health Wales NHS Trust
9Quadram Institute Bioscience
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Thomas R. Connor
  • For correspondence: e.volz@imperial.ac.uk a.rambaut@ed.ac.uk ConnorTR@cardiff.ac.uk
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Supplementary material
  • Data/Code
  • Preview PDF
Loading

Summary

In February 2020 a substitution at the interface between SARS-CoV-2 Spike protein subunits, Spike D614G, was observed in public databases. The Spike 614G variant subsequently increased in frequency in many locations throughout the world. Global patterns of dispersal of Spike 614G are suggestive of a selective advantage of this variant, however the origin of Spike 614G is associated with early colonization events in Europe and subsequent radiations to the rest of the world. Increasing frequency of 614G may therefore be due to a random founder effect. We investigate the hypothesis for positive selection of Spike 614G at the level of an individual country, the United Kingdom, using more than 25,000 whole genome SARS-CoV-2 sequences collected by COVID-19 Genomics UK Consortium. Using phylogenetic analysis, we identify Spike 614G and 614D clades with unique origins in the UK and from these we extrapolate and compare growth rates of co-circulating transmission clusters. We find that Spike 614G clusters are introduced in the UK later on average than 614D clusters and grow to larger size after adjusting for time of introduction. Phylodynamic analysis does not show a significant increase in growth rates for clusters with the 614G variant, but population genetic modelling indicates that 614G increases in frequency relative to 614D in a manner consistent with a selective advantage. We also investigate the potential influence of Spike 614D versus G on virulence by matching a subset of records to clinical data on patient outcomes. We do not find any indication that patients infected with the Spike 614G variant have higher COVID-19 mortality, but younger patients have slightly increased odds of 614G carriage. Despite the availability of a very large data set, well represented by both Spike 614 variants, not all approaches showed a conclusive signal of higher transmission rate for 614G, but significant differences in growth, size, and composition of these lineages indicate a need for continued study.

Competing Interest Statement

The authors have declared no competing interest.

Funding Statement

EV acknowledges the MRC Centre for Global Infectious Disease Analysis MR/R015600/1. VH was supported by the Biotechnology and Biological Sciences Research Council (BBSRC) [grant number BB/M010996/1]. JTM, RMC, NJL and AR acknowledge the support of the Wellcome Trust (Collaborators Award 206298/Z/17/Z ARTIC network). AR is supported by the European Research Council (grant agreement no. 725422 ReservoirDOCS). DLR is supported by the MRC (MC_UU_1201412). J.S. was supported by the Biotechnology and Biological Sciences Research Council-funded South West Biosciences Doctoral Training Partnership [training grant reference BB/M009122/1]. T.R.C. and N.J.L. acknowledge support from the MRC which funded computational resources used by the project [grant reference MR/L015080/1]. T.R.C. acknowledges funding as part of the BBSRC Institute Strategic Programme Microbes in the Food Chain BB/R012504/1 and its constituent projects BBS/E/F/000PR10348 and BBS/E/F/000PR10352]. A.P. and T.R.C. acknowledge support from Supercomputing Wales, which is part-funded by the European Regional Development Fund (ERDF) via Welsh Government. The project was also supported by specific funding from Welsh Government which provided funds for the sequencing of a subset of the Welsh samples used in this study, via Genomics Partnership Wales. COG-UK is supported by funding from the Medical Research Council (MRC) part of UK Research & Innovation (UKRI), the National Institute of Health Research (NIHR) and Genome Research Limited, operating as the Wellcome Sanger Institute.

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

The study presented encompasses two elements. The first of these does not require specific ethical approval, as it focuses on public health/surveillance questions that make use of sequence data and other metadata that is already shared with the wider world as part of the activities of the COG-UK consortium (https://www.cogconsortium.uk/). COG-UK data is released and is publicly available via the ENA, GISAID and the COG-UK website. The element of the work that would/could require ethical approval is the specific examination of pathogenicity using mortality data from PHE. This work is covered as part of the COG-UK project protocol which was approved by the Public Health England Research Support and Governance Office (RSGO) following review by the PHE Research Ethics and Governance Group (REGG).

All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Data Availability

All sequence data and metadata used in this work is shared via: The COG-UK website : https://www.cogconsortium.uk/data/ GISAID: https://www.gisaid.org/ and the ENA as part of Bioproject PRJEB37886: https://www.ebi.ac.uk/ena/data/view/PRJEB37886

https://www.cogconsortium.uk/data/

https://www.ebi.ac.uk/ena/data/view/PRJEB37886

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY 4.0 International license.
Back to top
PreviousNext
Posted August 04, 2020.
Download PDF

Supplementary Material

Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
Evaluating the effects of SARS-CoV-2 Spike mutation D614G on transmissibility and pathogenicity
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Evaluating the effects of SARS-CoV-2 Spike mutation D614G on transmissibility and pathogenicity
Erik M. Volz, Verity Hill, JT McCrone, Anna Price, David Jorgensen, Áine O’Toole, Joel Southgate, Robert Johnson, Ben Jackson, Fabricia F. Nascimento, Sara M. Rey, Samuel M. Nicholls, Rachel M. Colquhoun, Ana Da Silva Filipe, Nicole Pacchiarini, Matthew Bull, Lily Geidelberg, Igor Siveroni, Ian G. Goodfellow, Nicholas J. Loman, Oliver Pybus, David L. Robertson, Emma C. Thomson, Andrew Rambaut, Thomas R. Connor
medRxiv 2020.07.31.20166082; doi: https://doi.org/10.1101/2020.07.31.20166082
Reddit logo Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools
Evaluating the effects of SARS-CoV-2 Spike mutation D614G on transmissibility and pathogenicity
Erik M. Volz, Verity Hill, JT McCrone, Anna Price, David Jorgensen, Áine O’Toole, Joel Southgate, Robert Johnson, Ben Jackson, Fabricia F. Nascimento, Sara M. Rey, Samuel M. Nicholls, Rachel M. Colquhoun, Ana Da Silva Filipe, Nicole Pacchiarini, Matthew Bull, Lily Geidelberg, Igor Siveroni, Ian G. Goodfellow, Nicholas J. Loman, Oliver Pybus, David L. Robertson, Emma C. Thomson, Andrew Rambaut, Thomas R. Connor
medRxiv 2020.07.31.20166082; doi: https://doi.org/10.1101/2020.07.31.20166082

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Epidemiology
Subject Areas
All Articles
  • Addiction Medicine (271)
  • Allergy and Immunology (557)
  • Anesthesia (135)
  • Cardiovascular Medicine (1769)
  • Dentistry and Oral Medicine (238)
  • Dermatology (173)
  • Emergency Medicine (316)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (662)
  • Epidemiology (10812)
  • Forensic Medicine (8)
  • Gastroenterology (594)
  • Genetic and Genomic Medicine (2960)
  • Geriatric Medicine (288)
  • Health Economics (534)
  • Health Informatics (1933)
  • Health Policy (836)
  • Health Systems and Quality Improvement (745)
  • Hematology (293)
  • HIV/AIDS (633)
  • Infectious Diseases (except HIV/AIDS) (12525)
  • Intensive Care and Critical Care Medicine (696)
  • Medical Education (300)
  • Medical Ethics (87)
  • Nephrology (324)
  • Neurology (2808)
  • Nursing (152)
  • Nutrition (433)
  • Obstetrics and Gynecology (559)
  • Occupational and Environmental Health (597)
  • Oncology (1473)
  • Ophthalmology (444)
  • Orthopedics (172)
  • Otolaryngology (257)
  • Pain Medicine (190)
  • Palliative Medicine (56)
  • Pathology (381)
  • Pediatrics (868)
  • Pharmacology and Therapeutics (367)
  • Primary Care Research (338)
  • Psychiatry and Clinical Psychology (2646)
  • Public and Global Health (5383)
  • Radiology and Imaging (1016)
  • Rehabilitation Medicine and Physical Therapy (597)
  • Respiratory Medicine (727)
  • Rheumatology (330)
  • Sexual and Reproductive Health (290)
  • Sports Medicine (279)
  • Surgery (327)
  • Toxicology (48)
  • Transplantation (150)
  • Urology (126)